FV Pharma International Corp.
Industrials · Wholesale-Drugs, Proprietaries & Druggists' Sundries · NV · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY14 | FY13 | |
|---|---|---|
| Revenue | $2,475 | $2,475 |
| Operating income | −$28,884 | $1,760 |
| Net income | −$28,884 | $1,408 |
| Total assets | $6,516 | $31,560 |
| Total liabilities | $0 | $552 |
| Equity | $6,516 | $31,008 |
| EPS (diluted) | — | — |
| Shares out. | 250.8M | 8.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2014- Operating margin
- −1167.0%
- Net margin
- −1167.0%
- Return on equity
- −443.3%
- Return on assets
- −443.3%
- Return on capital (ROCE)
- −443.3%
- Liabilities / assets
- 0.0%
- Debt / equity
- 0.00×
- Book value / share
- $0.00
- Revenue growth (YoY)
- 0.0%
- Net income growth (YoY)
- −2151.4%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2014- Accruals / assets
- 39.9%high accruals
- Piotroski F-Score
- 2/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 5 warning● 1 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- High accruals — earnings-quality risk
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗May 2, 2014
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Prior financials not reliable (restatement)Feb 27, 2015
- Amended charter or bylawsAug 12, 2014
- Other material eventJun 16, 2014
- Other material eventMay 2, 2014
- Amended charter or bylaws · Other material eventApr 17, 2014
- Change in control · Director / officer changeFeb 7, 2014
- Changed auditorDec 2, 2013
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KFeb 27, 2015
- 10-QFeb 18, 2015
- 10-QFeb 18, 2015
- 8-KFORM 8-KAug 12, 2014
- 10-QQUARTERLY REPORTJun 20, 2014
- NTN 10QNOTIFICATION OF LATE FILINGJun 18, 2014
- 8-KCURRENT REPORTJun 16, 2014
- 10-K/AAMENDMENT TO FORM 10-KMay 28, 2014
- 10-KANNUAL REPORTMay 16, 2014
- 8-KCURRENT REPORTMay 2, 2014
- NT 10-KNOTIFICATION OF LATE FILINGMay 2, 2014
- 8-KCURRENT REPORTApr 17, 2014
- 8-KCURRENT REPORTFeb 7, 2014
- 10-QDec 11, 2013
- 8-KDec 2, 2013
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.